MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$15.85 0.23 (1.47%)
Open Price: 15.86
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients